Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Comment by lscfaon May 03, 2022 5:59pm
199 Views
Post# 34652919

RE:Q1

RE:Q1

 

Qtr ending

Vent patients

Vent rev

Other core rev

Covid rev

Total rev

adj ebitda 

ebitda margin

Jun 22 (e)

 

 

 

 

32,700

 

 

Mar 22

8,434

21,518

8,642

2,095

32,255

7,273

22.5%

Dec 21

8,405

21,888

7,059

3,015

31,962

9,549

29.9%

Sep 21

8,200

21,305

6,528

1,452

29,285

7,419

25.3%

Jun 21

8,103

20,305

5,958

1,136

27,399

6,847

25.0%

Mar 21

7,733

20,351

5,110

2,955

28,416

5,468

19.2%

Dec 20

7,892

20,581

5,547

5,074

31,202

9,458

30.3%

Sept 20

7,788

19,962

4,932

8,553

33,447

7,720

23.1%

Jun 20

7,705

18,951

4,191

19,712

42,854

16,287

38.0%

Mar 20

7,965

18,792

3,974

1,040

23,806

7,869

33.1%

 

<< Previous
Bullboard Posts
Next >>